2.01
price up icon2.55%   0.05
after-market Handel nachbörslich: 1.99 -0.02 -1.00%
loading

Finanzdaten der Genprex Inc-Aktie (GNPX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Research and Development
12.27%
2.1929
2.4995 2.54 2.8385 2.7561
Costs And Expenses
28.53%
3.3459
4.6818 3.9693 4.3357 4.3234
Operating Income/Loss
28.53%
-3.3459
-4.6818 -3.9693 -4.3357 -4.3234
Income/Loss From Continuing Operations Before Tax
28.43%
-3.3459
-4.6749 -3.9646 -4.3357 -4.3234
Income/Loss From Continuing Operations After Tax
18.73%
-3.7992
-4.6749 -3.9646 -4.3305 -4.316
Net Income/Loss
18.73%
-3.7992
-4.6749 -3.9646 -4.3305 -4.316
Preferred Stock Dividends And Other Adjustments
-
- - 0.2771 -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
97.24%
0.7605
27.59 15.27 1.5743 3.4998
Basic Earnings Per Share
2,841%
-5.00
-0.17 -0.26 1.56 -1.23
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - 0.2771 -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):